Evidence map›Paper›PMID 40095994›Full record

ArticleJournal of visualized experiments : JoVE2025

Characterizing Extracellular Vesicles from Biological Fluids.

Brenna S Hefley, Pawan Shrestha, Brenda Vasini, Purnima Sharma, Dimitrios Karamichos

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brenna S HefleyNorth Texas Eye Research Institute, University of North Texas Health Science Center; Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center.
Pawan ShresthaNorth Texas Eye Research Institute, University of North Texas Health Science Center; Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center.
Brenda VasiniNorth Texas Eye Research Institute, University of North Texas Health Science Center; Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center.
Purnima SharmaNorth Texas Eye Research Institute, University of North Texas Health Science Center; Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center.
Dimitrios KaramichosNorth Texas Eye Research Institute, University of North Texas Health Science Center; Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center; Department of Pharmacology and Neuroscience, University of North Texas Health Science Center; Dimitrios.Karamichos@unthsc.edu.

Funding

Sphingolipids and their Impact in Corneal Wound HealingR01EY031316 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KARAMICHOS, DIMITRIOS, MANDAL, NAWAJES · 2020 to 2023
$1.8M
The role of extracellular vesicles in keratoconus pathogenesisR21EY034714 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI KARAMICHOS, DIMITRIOS · 2023 to 2024
$407k
NEI NIH HHS R01 EY031316NEI NIH HHS R21 EY034714
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are structures that are produced from cells and participate in intercellular communication by transporting biomolecules from one cell to another. EVs have been shown to travel short and far distances in the body and are tissue-specific. EVs are not only found in tissues, but they can also be found in practically all bodily fluids, such as tears, saliva, cerebral spinal fluid, blood, etc. Even though EVs can be collected non-invasively from tears and saliva, only small volumes can be collected at a time, which can cause issues in obtaining enough EVs to analyze proteins. The scanner discussed in this paper is a nanoparticle analyzer that provides a solution to this problem, allowing us to characterize and study the phenotype, size, and total particle count of EVs from as little as 1 µL of biological fluid. This protocol will expand the knowledge of EVs from small volumes of samples that are difficult to extract from patients. This could enhance patient comfort and potentially identify new therapeutic targets for a range of diseases and disorders.

Indexed as

Body FluidsExtracellular VesiclesHumansNanoparticles

Identifiers

PMID40095994
PMCPMC13482501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.